Table 1.

Breast tumor and non-tumor cell lines.

Cell line	Genetic subtype	ER	PR	Her2	TP53	N-cadherin	Shape cluster
hs578T	BaB	−	[−]	−	+M	++	B
MCF10A (complete medium)	BaB	−	[−]	−	+/−WT	++	L/B
MCF10A (base medium)	BaB	−	[−]	−	+/−WT	++	L2
MDAMB157	BaB	−	[−]	−	−	++	B
MDAMB231	BaB	−	[−]	−	++M	−	B
SUM149	BaB	[−]	[−]	−	[+]	+	B
SUM159	BaB	[−]	[−]	−	[−]	++	L/B
HCC1143	BaA	−	[−]	−	++M	++	B
HCC1954	BaA	−	[−]	+	[+/−]	−	L1
HCC70	BaA	−	[−]	−	++M	−	L2
AU565	Lu	−	[−]	+	+WT	−	L2
BT474	Lu	+	−	+	+	−	L2
CAMA1	Lu	+	[−]	−	+	−	L2
MCF7	Lu	+	[+]	−	+/−WT	−	L1
MDAMB453	Lu	−	[−]	−	−WT	−	L2
SKBR3	Lu	−	[−]	+	+	−	B
T47D	Lu	+	[+]	−	++M	−	L1
ZR75.1	Lu	+	[−]	−	−	−	L2
JIMT1		−	[−]	+	++	−	L1

Gene cluster: Lu = luminal, BaA = Basal A, BaB = Basal B. ER/PR/HER2/TP53 status: +/− from protein and mRNA expression; [−] inferred from mRNA expression; M = mutant, WT = wild-type (Neve et al, 2006). N-cadherin status: +/− from mRNA expression and immunofluorescence (Supplementary Fig S1B). Shape clusters assigned from hierarchical clustering shown in Fig1D.